article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D.,

article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Centered on digital biomarker and safety monitoring algorithm development, with a specific emphasis on cytokine release syndrome (CRS) detection, the oncology programs harness cutting-edge data science and technology to elevate remote data collection, patient monitoring, and safety protocols. Full press release here

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

Lloyd Price

Hospitals and healthcare systems are increasingly implementing AI tools for tasks like medical imaging analysis, drug discovery, and even robot-assisted surgery. With this rapid adoption, there's a need for dedicated leadership to guide responsible and strategic implementation.

article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

In Health Care, AI to Advance Rapidly Along With Its Regulation

Healthcare IT Today

He also said that the benefits go beyond doctors; for instance, care coordinators can be more efficient and AI can help drug development. Nair suggested that AI can make it easier to manage health care regulations, on which a hospital spends 8 million dollars a year on average.

article thumbnail

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare.